SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla’s arm acquires additional 15.10% stake in Cipla Maroc SA

28 Nov 2023 Evaluate

Cipla’s wholly owned subsidiary -- Cipla (EU) has completed acquisition of additional 15.10% in the Cipla Maroc SA, Morocco, (JV Co.), from The Pharmaceutical Institute (PHI) for a consideration of Moroccan Dirham 81.1 million on November 24, 2023. 

Accordingly, Cipla EU will now hold 75.10% stake in the JV Co. and balance 24.90% stake will be held by Societe Marocaine De Cooperation Pharmaceutique (CooperPharma).

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1238.30 7.55 (0.61%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×